Managing cardiometabolic diseases holistically with technology
With cardiometabolic diseases negatively impacting upwards of 47 million people in the U.S. each year, it is important for physicians to understand the origin of the disease in order to develop successful chronic care programs.
In short, cardiometabolic syndrome is a single underlying disease state with obesity at its foundation that manifests differently in individual patients. More inclusive than its origins in metabolic syndrome (MetS) – a similar condition characterized by biometric abnormalities – cardiometabolic syndrome encompasses individuals with diagnosed chronic diseases such as type 2 diabetes, cardiovascular disease and non-alcoholic fatty liver disease.
Adverse Effects of Cardiometabolic Disease
Studies have shown that individuals with cardiometabolic syndrome are two times more likely to die from coronary heart disease – the leading cause of death for American men and women – and three times more likely to have a heart attack or stroke in their lifetime.
Keeping these variables in mind, today’s physicians are also faced with the cost factor of managing these conditions. In addition to being the leading killer of Americans, statistics show cardiometabolic diseases are some of our nation’s costliest diseases to date. In fact, the total annual healthcare cost per patient with one component of cardiometabolic syndrome is more than $5,000, while the cost of care for those with four components nearly triples.
How Technology Can Assist in the Fight Against Cardiometabolic Syndrome
Before developing any chronic care management plan to fight cardiometabolic syndrome, however, care teams must:
- Empower patients and colleagues to start thinking about cardiometabolic disease more holistically
- Begin to address the effects of obesity based on the latest evidence and guidelines as a disease
- Focus on reducing the risk of adverse cardiovascular events
Luckily, recent advancements in health IT are equipping care teams to fight back against the damaging effects of cardiometabolic disease.
One such technology is Rimidi’s cloud-based software platform that enables personalized management of chronic cardiometabolic conditions across the care continuum--from in the doctor's office to home. Launching directly within the EHR, the platform combines patient-generated data from connected devices – such as scales, glucometers, continuous glucose monitors, blood pressure cuffs and activity trackers – with relevant clinical data from the electronic health record to enable physicians to better identify gaps in care.
The platform then extracts the pertinent data from these sources and (based on the latest evidence and guidelines) flags any abnormalities or potential risk factors that otherwise might be buried within a patient’s medical record for the clinician or care team.
A solution created by doctors, Rimidi unlocks the meaning in patient data for better outcomes, which ultimately results in a better healthcare system for all.
To learn how our platform can help your practice or health system deliver a more efficient cycle of care, contact a member of our team today.
Recent News & Insights
When it comes to digital health innovation, Rimidi has consistently been at the forefront. …